Drugs / CD34+ cells
last change Jun 2018 re-read 2 minutes ago

CD34+ cells

Developed for
dilated cardiomyopathy · heart failure

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT02248532 Comparator Jan 2014 → Sep 2017 dilated cardiomyopathy, heart failure University Medical Centre Ljubljana Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as CD34+ cells “80 million CD34+ cells were collected by apheresis and injected transendocardially.” PMID 29880546 Jun 2018
Route Other “Intramyocardial delivery of cell suspension will be performed with the MyoStar (BiosenseWebster®, Diamond Bar, CA) injection catheter.” NCT02248532